Dr. Lippman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3970 reservoir rd nw
Washington, DC 20007Phone+1 202-687-2205
Education & Training
Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1973 - 1974
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1970 - 1973
Johns Hopkins UniversityResidency, Internal Medicine, 1968 - 1970
Yale School of MedicineClass of 1968
Certifications & Licensure
DC State Medical License 2018 - 2024
FL State Medical License 2007 - 2019
MI State Medical License 2000 - 2008
MD State Medical License 1970 - 2002
ME State Medical License Active through 1995
CT State Medical License 1973 - 1982- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Top Doctors:South Florida Castle Connolly, 2012
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 54 citationsTwenty-five year results of the national cancer institute randomized breast conservation trialNicole L. Simone, Tu Dan, Joanna Shih, Sharon L. Smith, Linda Sciuto
Breast Cancer Research and Treatment. 2012-02-01 - 515 citationsAvelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.Luc Dirix, István Takács, Guy Jerusalem, Petros Nikolinakos, Hendrik Tobias Arkenau
Breast Cancer Research and Treatment. 2018-10-23 - 517 citationserbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast CancerSoonmyung Paik, John Bryant, Chanheun Park, Bernard Fisher, Elizabeth Tan-Chiu
Journal of the National Cancer Institute. 1998-09-16
Journal Articles
- Endocrine Adjuvant Therapy for Localized Breast CancerMarc Lippman, MD, The New England Journal of Medicine
Press Mentions
Dan Hayes Witnessed Cancer History, Now He Is Documenting It in a PodcastJune 4th, 2021
Grant Support
- Training Grant In Tumor BiologyNational Cancer Institute1996–2001
- Cancer Center Support GrantNational Cancer Institute1993–2000
- Clinical Oncology Research Career Development ProgramNational Cancer Institute1997–1999
- Spore In Breast CancerNational Cancer Institute1995–1998
- Core--Developmental FundsNational Cancer Institute1993–1996
- Conference On Breast And Prostate CancerNational Cancer Institute1994
- Breast CancerNational Cancer Institute1994
- Special Project On Research Excellence--Breast CancerNational Cancer Institute1993–1994
- Developmental Research Program--Breast CancerNational Cancer Institute1992–1994
- Career Development--Breast CancerNational Cancer Institute1992–1994
- Growth Regulation As Targets In Breast Cancer TreatmentNational Cancer Institute1990–1994
- Extramural Research Facilities Contruction ProjectsNational Cancer Institute1993
- Ccsg For The Vincent T Lombardi Cancer Research CenterNational Cancer Institute1990–1993
- Specialized Program Of Research Excellence/Breast CancerNational Cancer Institute1992
- Conference On Breast And Prostate CancerNational Cancer Institute1992
- Suppoort Grant For Lombardi Cancer Research CenterNational Cancer Institute1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
